Lipoatrophy
Information
- Disease name
- Lipoatrophy
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00139178 | Completed | Phase 4 | Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. | March 2004 | April 2007 |
| NCT00307164 | Completed | Phase 2/Phase 3 | Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy | September 2006 | December 2008 |
| NCT00312832 | Completed | N/A | Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy | January 2004 | February 2005 |
| NCT00978237 | Completed | Phase 4 | Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients | October 2009 | November 2013 |
| NCT01828723 | Completed | Phase 1 | Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells | April 2013 | January 2015 |
| NCT02647853 | Completed | Phase 1 | Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers | October 2014 | December 2014 |
| NCT02914886 | Completed | Phase 4 | Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) | September 2016 | April 2019 |
| NCT05608239 | Not yet recruiting | N/A | Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane Injections | November 2022 | November 2023 |
| NCT04860063 | Unknown status | Phase 3 | Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. | April 2021 | July 2022 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100578